Pharmaceutical giant Gilead has agreed to release its exclusive patent to manufacture and sell the HIV-prevention drug Truvada. This means we could see a generic version of the pre-exposure prophylaxis (or PrEP) on the market earlier than expected. T…

from Engadget RSS Feed https://engt.co/2PVSA09
via IFTTT